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Abstract
Chronic Traumatic Encephalopathy (CTE) is a traumatic brain injury based disease that is garnering a lot of
attention in the United States. The purpose of this paper is to conduct an extensive review of the information
available about the condition. Recently there has been a limited amount of published information and treatment
opportunities are rare since the only way of diagnosing has come post mortem. Various literary reviews and
experiments were analyzed for appropriate information regarding CTE’s pathology and treatments and only peer
reviewed published works were allowed in this paper. This resulted in promising information about the disease and
the future treatments for the condition were viewed and will be used throughout this article.
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Until recent development of advanced imaging
technology very little was known about brain
injuries. The brain is relatively hidden inside of a
skull and there is limited viewing options
without expensive imaging techniques (13).
With these limitations, understanding of how
impact to the head affected the brain was
severely hindered, and only showed symptoms
could be used to diagnose (7). Traumatic brain
injuries (TBI) were considered any significant
jolt or blow to the head that results in altered
brain function or feeling (2). Many of the
complications of severe traumatic brain injuries
are well documented and established but the
focus of this review is to highlight the mild
traumatic brain injury (mTBI) known as the
concussion and its correlation to CTE (10). A
mild traumatic injury is a blow or jolt to the
brain caused by a non-penetrating stimulus.
Concussions are mild traumatic injuries that
may have varying levels of severity, going from
momentary dizziness to a brief loss of
consciousness. Rarely are the immediate effects
of the concussion long lasting so a mTBI was
seen as harmless until recently (7). The
correlation of concussions in collision based
activities was tied to the onset of the disease

Figure 1: CTE Timeline (7)

CTE (Chronic Traumatic Encephalopathy) and
the medical communities’ attitude towards this
injury changed (7).
CTE has an increasing impact in the world of
neuroscience. CTE is known as a progressive
tauopathy neurodegenerative disease (7).
Before examining the clinical aspect of the
disease this paper will first review a brief history
of the condition. The first observed cases of CTE
were thought to have come in the early 1900’s
with boxing (2). In 1928 the term “punch drunk”
was coined to describe the unpredictable
behavioral, motor and cognitive functions
coming from years of repeated nonlethal blows
to the head, 10 years later Dr. Millspaugh called
it dementia pugilistica and shortly changed to
psychopathic deterioration of pugilists (7). In
1949 the name Chronic Traumatic
Encephalopathy was used and was cemented by
Dr. Critchley (17). Over the next 30 years the
scope of potential victims of CTE broadened to
include all contact sports and the military with
an especially high prevalence in football (Shown
in figure 1). All of these sports would include
repeated sub lethal blows to the head, often
resulting in concussions.

Chronic Traumatic Encephalopathy begins to
present symptoms 8-10 years after
experiencing repeated head injuries, these
symptoms are highlighted by headaches, rapid
mood swings, impulsivity, increased irritability,
aggression, memory loss, varying levels of
depression and in some cases gait
abnormalities; the most severe symptoms are
suicidal thoughts and actions (2). The most
recognizable physical symptom of CTE is the
atrophy of the following key brain regions:
cerebral cortex, temporal lobes, thalamus,
mammillary bodies and the brain stem, leading
to an abnormally low brain weight which leads
to the observed symptoms above (2). CTE
shares many signs and symptoms with
Alzheimer’s disease, ALS and Parkinson’s
disease which is why for years there was limited
ability to distinguish CTE from other
neurodegenerative disorders (1). CTE is initiated
from repetitive mild traumatic brain injuries.
These injuries cause widespread disposition of
neurofibrillary tangles composed of hyper
phosphorylated tau proteins, instead of the
regularly phosphorylated tau. There is also a
concentration of neurotoxic peptides beta
amyloid and TDP-43 and PNN destruction (9).
There has even been a possible gene
association with CTE (3). The APOE e4 allele is
linked with increased susceptibility (3).
Neurodegenerative disorders are clinically
distinguishable by the source of the brains
degeneration. Neurodegeneration is the single
most devastating effect of CTE and brain
degeneration is always fatal when untreated.
When this occurs, it will result in death unless
the patient succumbs to another cause of death
before the level of degeneration becomes fatal
(9).

CTE Specific Pathologies

TAU: The primary cause of neuronal

degeneration in CTE comes at the hand of the
neurofibrillary tangles caused by the Tauprotein, a condition commonly seen in
Alzheimer’s disease and other frontotemporal
dementias (1). Neurofibrillary tangles are
consisted of aggregated straight or paired
helical filaments, twisted ribbons and other
forms of overly phosphorylated forms of the
microtubule associated protein (MAP) known as
tau (16). These lesions are the diagnostic
hallmark of the condition, which as of now is
hard to find with the currently available forms
of imaging (16). It is increasingly evident that
tau-mediated neurodegeneration is the result
of a toxic gain of function mutation acquired by
the tau that come from over phosphorylation of
tau in the disease state (16). It is known that tau
is key in the organization and stabilization of
microtubules used in the central nervous
system, which is very important in the
structural organization of the brain (6). It is
believed that tau may also have additional roles
in its interaction with other structures and
enzymes such as the actin in the cytoskeleton
and tyrosine kinases (6). The build-up of p-tau
causes changes in these structures but exactly
how this change is caused is not quite
understood (1). One of the likely scenarios is
that once tau is phosphorylated, it enters an
extremely active state where it interacts with
the surrounding cellular structures that it
normally would not influence (5). These
reactions cause proteins in the brain to fold
improperly, which triggers apoptosis (6). This
error is considered a post translational
modification because in the early stages of tau
pathology there isn’t a change in the genetic
properties; there is just an over
phosphorylation of a protein triggered by
structural damage (6). Other post translational
modifications of tau include glycation,
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ubiquitination, sumoylation and nitration (1).
These are believed to occur at different stages
of tau pathology and could be possibly be a way
to establish how long CTE has been present in
the patient.
The ability for tau to modulate microtubule
properties contributes to key structural and key
regulatory cellular functions (9). Microtubules
play major roles in maintaining neuronal
morphology, the process that extend over long
distances make the neuron the most
asymmetrical of the cells so this morphology is
important (16). Microtubules are also key in the
transport machinery of neurons which allows
the signaling molecules to move into or out of a
cell. Under normal cell condition tau is in a
constant equilibrium on and off the
microtubules, being activated and deactivated
when necessary (25). This equilibrium is
controlled by the phosphorylation state of tau
by kinases (1). In the case of a repetitive
traumatic brain injuries the protein tau
becomes phosphorylated at an increasingly high
rate. The buildup of phosphorylated tau
proteins leads to axonal transport defects,
synapse loss and neuroinflammation (25).
Studies of this protein have shown that the
disengagement of tau from microtubules via
phosphorylation is a critical step in the tau
mediated neurodegeneration (1). There is a
threshold of free phosphorylated tau that must
be reached before it becomes toxic to the brain,
and with traumatic brain injuries the amount of
p-Tau increases. When the p-Tau level becomes
toxic neurons begin to die and the Tau deposits
spread (16).

Other neurotoxic peptides and PNN:
Another symptom of repeated blows to the
head is the disruption of the Perineuronal Net
(PNN) (14). PNN’s represent the highly

organized components of the brains
extracellular matrix (5). These nets surround
cell bodies, dendrites and axons of particular
classes of neurons forming lattice like
structures. The roles of PNN’s are not
completely understood yet, but they do play a
beneficial role by stabilizing the extracellular
matrix by protecting them from harmful agents
(14). These barriers against chemical agents
form a physical gate between the neural tissue
and ECM. They create a barrier that limits
neuronal plasticity and counteracts
regeneration of neuronal circuits (6).
The extracellular matrix in the central nervous
system contains a highly organized mixture of
proteoglycans, tenascin, fibronectin and a
scaffolding substance called hyaluronan (6).
These materials are dispersed all around the
CNS but only particular neurons are enveloped
completely by these PNN’s. The main
component of the PNN is the proteoglycan. The
specific proteoglycan varies depending on what
type of cell the PNN is protecting (6). It is
believed that the disruption of these PNN’s
helps allow the hyper phosphorylated tau
protein to build up in the brain when there is
damage to the brain. The repellant properties
of the PNN is compromised when there is
damage and molecules that may naturally exist
in the extracellular space are allowed contact
with neurons and may be toxic (14). Along with
the direct toxic effects of the tau protein, the
damage to the PNN also releases the Amyloid
beta peptide. This peptide is a natural occurring
peptide in the body but when it is free in the
extracellular matrix it initiates an immune
response because the peptides are recognized
as foreign, causing massive inflammation (15).
The charge of the beta amyloid causes them to
move towards neurons because that is their
natural place as part of the PNN forming what is
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called a senile plaque (similar to senile
associated brain images) (14). This throws off
the ionic balance and conductivity of the
neurons, ultimately disrupting brain function.
The immune response against these peptides
near the neurons results in self damage in an
attempt to remove the toxic peptides. When
the plasticity limiting properties of PNN’s are
very important to the way the brain
communicates with the rest of the body and
other areas of the brain (14). The brain
primarily has 3 types of non-specialty neurons;
those being inhibitory, excitatory and
interneurons. The buildup up of the tau protein
and beta amyloid peptide demonstrate a prion
like toxic effect on PNN of the GABAergic
neuron which is an interneuron (12). PNN show
a very limited ability to regenerate on their
own, leading to possible movement of neurons
if repeated blows to the brain are received.
Interneurons connect different areas of the
brain, which is necessary for parallel processing
used on a daily basis in human life.
Overstimulation or under stimulation from a
rearranged interneuron caused by traumatic
brain injuries could be devastating to the
normal processing ability of the brain (2).
One preexisting condition that has been
correlated with the onset of CTE is genetic (27).
The gene apolipoprotein correlated to tau
transcription has two versions, (apopE3) and E4
(apopE4) (27). ApopE4 when combined with
traumatic brain injury resulted in a high risk of
tau protein based neurodegenerative disorders
were 2-4 times more likely than those with the
E3 gene. This research was conducted in mice
models, and it is believed the human brain
follows the same physiological properties (28).
In a study with TBI blasts conducted on mice
those with the gene ApopE3 had levels of PIP2
phosphate elevated which lead to a reduction in

the PIP2 degrading enzyme synj1. In the mice
with the ApopE4 gene the blast induced TBI the
PIP2 phosphate levels did not change so there
was no down regulation in synj1 (3). Soon after
it was discovered that the amount of p-Tau in
the E4 type dramatically outgained the amount
in the E3 genotype. PIP2 is a signaling lipid that
is involved with ion channel homeostasis,
exocytosis and endocytosis. It also plays a role
in cytoskeletal configuration and cell signaling.
The enzyme SYNJ1 is responsible for the
degradation of PIP2 (3).
The experiment used to find these results were
done by inducing a blast that would cause a
non-penetrating TBI (4). The blast measured
was blowing up a stick of TNT at a distance of 6
meters from the subject. In the study, it was
observed that in the CTE susceptible ApoE4
genotyped subjects reduces PIP2 levels in
mouse and in human brains but that reduction
doesn’t happen early in the life of the mouse
(4). Through the first 3 months of the life of the
mouse the PIP2 levels post blast, remained
constant between the two genotypes. This lead
to the hypothesis that continued exposure to
blasts causing TBI alters something in the ApoE4
gene that is not in ApoE3(4). Interestingly
enough, when the mRNA post blast was
compared to the mRNA pre blast in each of the
genotypes there was no observed change which
lead to the new hypothesis that the true change
in the gene expression came from a post
transcriptional or post translational alteration.
The steps of DNA to protein is a highly
regulated process, The DNA (gene) under goes
selection via a transcription factor, then
undergoes transcription to create mRNA and
then the mRNA is translated into a protein. In
this experiment there is no alteration prior to
transcription meaning that the DNA itself is not
altered but there is an epigenetic change (28).
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The conclusion gathered from these
observations is that when the SYNJ1 enzyme is
down regulated after a TBI in the ApoE3
genome subjects, there is no dysregulation of
PIP2 levels meaning no free phosphates capable
of binding to tau proteins (4). The ApoE4 mice
do not down regulate SYNJ1 causing an
abundance of phosphates in the cell. This

research concluded with observation that either
gene provided subjects that tested positive for
hyper phosphorylated tau but the ApoE4
genotype provided a much higher rate of p-Tau,
an indicator of CTE (3).

Below is an image of a brain that tested positive for the pathologies explained. The clear neurodegeneration can
be seen in the brain (10).

Figure 2: Comparative Imaging of 2 Brains (10)

Cerebral Cortex:
The largest portion of the human brain is the
cerebral cortex, and it plays a large role in
memory, attention, perception, cognition,
awareness, thought, language and
consciousness. The reason it is called the
cerebral cortex (thinking region) is because
essentially all activities that are involved with
our consciousness are coordinated here. It is
located at the most anterior placement of the
brain right behind your skull, effectively
encasing the whole brain acting as the
outermost “layer” for an idea of the location
(10). The outer zone of the cerebral cortex is
made up of neural tissue called gray matter.
This is where the neuronal cell bodies are. The
cerebral cortex is typically folded in order to

increase surface area, allowing more space for
more neurons in the limited space of the
cranium (20). The different areas of the cerebral
cortex are directly correlated with different
functions which is why the initial side-effects of
a TBI can vary because depending on where the
bruising occurs there will be area specific
symptoms (24). Initially after a TBI the swelling
caused in the aftermath of tissue damage
causes pressure to build pushing the cerebral
cortex against the skull and interfering with all
of the functions previously stated (20). This is
why a swollen brain can result in difficulty in all
conscious activity, but many of the
subconscious activities remain functional
(breathing, heart rate) (19). When the
neurodegeneration from p-tau accumulation

9

begins, the cerebral cortex is usually the first
place the damage is seen (17).

Temporal Lobe:
Interestingly enough, in many of the TBI cases
an area of the cerebral cortex that initially
suffers the most damage is the temporal lobe
(8). The temporal lobe is responsible for
establishing new memories, processing
language and object recognition, which are
three things a patient who suffers from CTE
struggle with (17). There are primarily two
different factors in this area specific damage
from TBI. One of the hypothesis for this is the
natural human reflex. Naturally when a person
see’s a dangerous stimulus coming directly at
them they turn their head away. This is seen
constantly in collision sports or near explosions
in an attempt to protect the eyes (10). When
something potentially dangerous is coming at
you, you close your eyes and turn away. With
the temporal lobe being located on the sides of
the brain right behind where the ears connect
to the head, they a prone to direct impact and
can sustain a significant amount of bruising
(13). The structure of the brain usually makes it
so there is an elastic type collision inside the
cranium which causes the side opposite of the
impact to absorb much of the physical damage
from the brain movement towards that side of
the skull (20).
A second type of mTBI that has been correlated
with concussions that damage the temporal
lobe specifically are blast induced TBI (bTBI) (4).

Between 10-20% of soldiers returning from
Operation Iraqi Freedom have suffered from at
least one of these injuries. The over
pressurization due to the shockwave from a
blast is the culprit for this type of damage. This
type of blast in recent warfare has been the
number one cause of mortality for American
troops (4). Blast waves specifically have an
effect on the organs with fluid filled membranes
(e.g. lungs, bowels, brain, etc.). The brain also
fits into that category because of the fluid filled
ventricles, and all of the vasculature dispersed
throughout the brain (8). The temporal lobe
specifically is where the hearing and vestibular
senses stimuli are relayed to understand the
environment (17). These senses respond to a
pressure gradient. When the shockwave of a
blast is induced there is an extreme increase in
pressure that feels like an extreme increase in
gravity. This outward pressure increase in
pressure causes such intense pressure increases
in the brain which then leads to the initial
damage to the brain (4). Secondary damage
comes from the hearing and vestibular fluid
sacs being stimulated so intensely that they are
over stimulating the brain, leading to the brain
increasing the threshold response which
ultimately would lead to the desensitization
towards normal stimulus. A result of this over
correction would be deafness and difficulty with
balancing. Both are common symptoms of
patients that have experienced blast
shockwaves (4). Since damage to the temporal
lobe is often seen with concussions caused by
TBI this area is usually the first to result in a
build-up of p-tau and the first area of CTE
mediated neurodegeneration (1).
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Figure 3. regions of the brain (29)

Limbic System
Thalamus/Hypothalamus: The thalamic region
is extremely important in the human brain (21).
It is given the task of receiving and relaying all
sensory signals to the correct portion of the
brain and also regulates consciousness, sleep,
alertness and emotions (21). TBI’s that cause a
change to the environment of the thalamus
would lead to a disruption in any of the
previously mentioned functions (21).
Concussions in particular) rarely cause direct
physical damage to the thalamus but the ones
that do result in the loss of consciousness which
can be permanent resulting in a coma.
Secondary effects from inflammation in the
non- thalamic regions in the brain lead to
increased pressure on the thalamus causing
impaired function. The primary side effects
from inflammation to the thalamus are delayed
reactions and processing of information (21).
The thalamus also integrates the limbic system

with the cerebral cortex which allows a person
to be aware of their emotions (21). At advanced
stages of CTE the p-Tau spreads toward the
thalamus and is especially toxic, resulting in
unpredictable emotions and difficulty sleeping
and waking caused by damage to efferent
neurons to the cerebral cortex (9). Damage to
the thalamus has been proven difficult to
correct because its location is in the middle of
the brain. Currently only medications have been
used in an attempt to correct the altered
neuronal functions (5), anti-inflammatory
medications reduce inflammation but the
physical damage to the tissue of the brain is
usually permanent, due to the inability for the
brain to heal itself fully (25).
Mammillary Bodies: The mammillary bodies
are a small region of the brain located between
the brain stem and the cerebrum (19). This twolobed structure has been associate with long
term memory and in other animals a sense of
direction also originates here. When the brain is
initially swollen after a TBI there can be a
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suppression of long term memory retrieval and
in the advanced stages of CTE there is
permanent memory loss (10).

Figure 4. Image of the inner regions of the brain (29).

Brain Stem:
The brain stem contains the centers for all of
the autonomic processes such as breathing,
cardiac and smooth muscle contractions and
the digestive tract (19). Non-penetrating
traumatic brain injuries that cause concussions
typically do not have enough force to cause
physical damage to the brain stem. The brain
stem becomes damaged when the spread of
hyper phosphorylated tau begins. This
interferes with the functioning of the neural
cells in the brain stem and leads to death. If a
brain stem is damaged there is usually a need
for respirator and feeding tube because the
autonomic functions are impaired (19).

Incidence and Diagnosis
The incidence of mTBI’s are hard to measure
because so many go unreported, which is why
an effort has been made to treat all head
injuries as if they were a concussion (22). It is

known that repeated traumatic injuries are the
only known link to CTE the most effective way
to stop the disease is to stop head injuries (7).
Realistically this is impossible, which is why
efforts to find a way to effectively diagnose the
disease. If the preventative measures cease and
repeated head injuries lead to a confirmed case
of CTE then a swift and effective treatment plan
must begin immediately (22). First an effective
way to diagnose CTE must be developed, and as
of November 2017 there may be a promising
development here. Until last November every
confirmed case of CTE has come post-mortem
(18). There have been no FDA approved
treatment plans for CTE but possible solutions
are in development. Led by Dr. Ben Omalu a
special PET scan that highlights the specific tau
protein deposits unique to CTE pathology has
been developed. Although there has been one
case observed, the subject that was observed
had a scan that was consistent with what post
mortem CTE subjects had shown. After the
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subject died the brain was dissected and CTE
was confirmed (18).
So far there have been no reported cases of CTE
in a person that has not experienced a
concussion or other non-penetrating traumatic
brain injury. Humans constantly place
themselves in situations where TBI is a risk (17).
Whether that is from the sports entertainment
world or the military, we have shown that we
are prone to placing ourselves into these
situations. Since there has been published
correlation of traumatic brain injuries and
neurodegenerative diseases the amount of
participants in the collision sports has declined
(7). Even though precautions for prevention
have been made there has been an increase in
the amount of concussions reported. This is
likely because of the increased attention to
head injuries has led to better recognition and
reporting of these injuries. It is widely believed
that the actual amount of concussions
sustained has lowered but the amount reported
has increased. In reality concussions can be
caused by many different things (9).

Treatments
When the preventative measures against
concussions fail serious complications can
occur, possibly leading to CTE. Many
pharmacological agents can help against
concussion symptoms, which may help prevent
CTE. These include anti-inflammatory
medications, cell cycle inhibitors, gene therapy
and stem cell therapy.

Anti-inflammatory and cell cycle
inhibitors: Drugs of this nature have the
ability to slow or even stop the progress of
secondary symptoms following a mTBI. This is

especially important in prevention of CTE
because the secondary symptoms of TBI’s are
what lead to CTE (5). An example of a
medication that helps combat these secondary
effects is minocycline. This drug is a tetracycline
that displays neuroprotective and antiinflammatory functions. It inhibits proinflammatory cytokines by suppression of IL1beta and IL-6 and also inhibits micro gliosis
(the process of CNS response to pathogens)
which leads to an effective prevention of
apoptosis in neuronal tissue. In recent human
trials it was shown that minocycline also
reduced serum nerurofilaments (12). This is
especially key in the case of CTE prevention
because the culprit in causing CTE is the protein
tau which comes from neurofilaments primarily
in the cytoskeleton (1).
Microglial proliferation after a mTBI is often
observed and glial cells are known as the
“quality controlmen” of the brain (23).
Microglia operate by removing the debris from
damaged regions and induce inflammation in
order to supply more blood to the damaged
area (12). The problem with inflammation in the
brain is that there is an enclosed volume so this
causes a pressure build-up which can alter brain
function (23). A way to prevent glial
proliferation and suppress this response would
be by inhibiting the cell cycle in CNS tissue. In
comparison to other areas of the body the brain
does not have much tolerance for new cell
growth after maturity (25). This is to protect the
carefully mapped neuronal networks and a
traumatic brain injury can cause already mature
neurons to undergo cell cycle activation which
leads to neuronal apoptosis. The drug
flavopiridol effects the cyclic-dependent-kinase
(CDK) inhibition which is the kinase signaling
that controls mitotic steps in the cell (9). In
human trials flavopiridol specifically blocked cell
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cycle activation in neurons, astrocytes and
microglia. Another inhibitor called roscovitine
has demonstrated its ability to inhibit CDK
causing a reduction in microglial activation,
neuroinflammation and neurodegeneration
weeks post injury.
The examples above are options that have
shown promising results in clinical trials but
more possible anti-inflammatory treatments for
the brain are still being developed. For example,
erythropoietin is a glycoprotein native to the
blood. It also has demonstrated
neuroprotective properties by altering a variety
of cellular and subcellular processes including
suppression of apoptosis, inflammatory and
antioxidative stress (9). This medication has not
yet made it to human trials but has been very
successful in the animal trials of TBI. A debate
with many of these anti-inflammatory and cell
cycle inhibiting drugs are what the possible
long-term effects will be (9). For example,
initially the drug class statins proved to be
effective in treating the secondary symptoms of
a TBI but case studies showed that long term
side effects resulted in attention deficits,
memory loss and decreased psychomotor
speed. Statins are used in medicine for a variety
of different reasons and now come with a FDA
placed warning for possible cognitive side
effects (9).

Biopharmaceuticals:

The previously

mentioned treatments are considered
pharmacological interventions but promising
advancements based on preclinical studies have
focused on the use of biologics (stem cells, gene
therapy).
Neural stem cells and mesenchymal stem cells
have shown the ability to restore and

regenerate the damaged area of the brain in
mouse models, therefore theoretically this
would do the same in humans. The problem is
that these stem cells have proven difficult to
reach without damaging the brain (5). The
number of available neuroblast (stem cells of
the brain) also decreases with age placing a high
demand for these neuroblast in age related
cases of neurodegeneration in comparison to
TBI. Another potential effective biological
application would be controlling the translation
process in gene expression. For example, the
inhibitory pathway that leads to RhoA
activation comes after a traumatic brain injury
(9). This is used to suppress neuronal growth
after damage has occurred in an attempt to
limit possible spreading of a pathogen. If the
activation of this pathway is blocked by
dephosphorylating, then the is potential for
neuron growth and regeneration. The inhibitor
used would be called a ROCK inhibitor and
could be an effective adjuvant to biologics for
enhancing recovery from TBI (9).

Noninvasive interventions:
Two potential non-invasive therapies have
possible benefits for TBI victims, those being
physical exercise and transcranial magnetic
stimulation (TMS) (30). Both have shown very
effective results in pre-clinical studies. These
have evoked neuroplasticity changes which
ultimately lead to recovery of pre-injury
functionality (30).

Conclusion:
CTE has a delayed pathology and this caused the
disease to receive less attention than warranted,
which delayed action to fund research towards
effective treatments and a possible cure (24).
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Although the discovery of CTE happened decades
ago, the recent correlation with football has made
it a lightning rod for conversation. With increased
influence from the public, more funding for
research backed by the National Football League.
As of now there have been no proven cures for
CTE, it must also be noted that having a
concussion does not guarantee you will have this
disease. Multiple concussions have been
correlated with onset CTE but there are many
people who have experienced multiple
concussions with no evidence of the disease (24).
The most effective treatment to CTE in the
general population has been to limit or eliminate
the risks of concussions. In all levels of football
targeting a player’s head can lead to ejection on
top of newer helmets that absorb kinetic energy
better than previous years (13). Combat sports
have altered their rules to protect heads better,
the United States military has spent millions of
dollars creating helmets to help with blast
shockwaves (4). If preventative measures fail,
then concussions must be treated with better
urgency; many victims believe they are not a
problem but slowly that mindset has begun to
change. With the seemingly effective diagnosis
protocol developed by Dr. Omalu if CTE is
suspected no longer will health care providers
wait until after death to observe neural tissue and
effective attempts to stop pathogenesis will occur
(18). In CTE confirmed live patient’s medications
can be used in trials to determine what is effective
and ideally cure the disease. Better dieting, and
supplements have been shown in mouse models
to prevent the onset of CTE and also directly help

with concussion recovery and prevention in
mouse observations. The fatty acid omega-3 has
shown this ability (26). Long term trials are being
conducted on whether or not this prevents CTE in
humans.
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Appendix A
The citations in this review were done with APA format using the scientific
numbering method. In the bibliography the sources are placed in alphabetical
order, with the numbers showing the order of citation added to this paper.

16

Appendix B
My external reviewers Dr. Michael J Boxenbaum and Dr. Scott Torness insisted that the content of this paper
was sufficient. The only suggestions made to me were to keep a consistent tone/ flow throughout the paper
and use citations even if I felt I knew the material without reading it in a journal. I have done my best to
incorporate this advice.
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